BioCentury | Feb 26, 2021
Distillery Therapeutics

Blocking COL1 for multiple sclerosis

...fibrotic scar area in the spinal cord. Ongoing work includes identifying the molecular mechanisms that drive fibrosis.Anima Biotech Inc....
BioCentury | Jul 11, 2019
Emerging Company Profile

Twentyeight-Seven’s bet on RNA-binding proteins

...the anti-snRNP200 preclinical mAb AT1331 to treat subtypes of acute myelogenous leukemia (AML). Like Twentyeight-Seven, Anima Biotech Inc....
...Netherlands American Association for Cancer Research (AACR), Philadelphia, Pa. American Society of Hematology, Washington, D.C. Anima Biotech Inc....
BioCentury | Jun 21, 2019
Tools & Techniques

A human CRISPR-like system adds a new approach to regulating translation

...Inc. and Ribometrix Inc. -- have systematic techniques for identifying RNA-binding small molecules. Another company, Anima Biotech Inc....
...it and using the platform as a starting point for a company. Companies and institutions Anima Biotech Inc....
BioCentury | May 24, 2019
Emerging Company Profile

Anima opens new target space in translational control

...of target stability, tissue selectivity and the ability to tune protein expression up or down. Anima Biotech Inc....
...translation of a protein could dramatically increase production capability and efficiency,” he said. COMPANY PROFILE Anima Biotech Inc....
...Patents: 5 issued covering undisclosed IP Companies and Institutions Mentioned Accent Therapeutics Inc., Lexington, Mass. Anima Biotech Inc....
BioCentury | Jul 27, 2018
Company News

Lilly pairs up with protein translation company Anima

...Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors...
...Huntington disease. Anima Biotech Inc., Bernardsville, N.J. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Pharmaceuticals Elizabeth S. Eaton Anima Biotech Inc. Eli...
BioCentury | Jul 23, 2018
Company News

Lilly pairs up with protein translation company Anima

...Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors...
...includes inhibitors to treat fibrosis, viral infections, cancer and Huntington disease. Elizabeth S. Eaton Eli Lilly and Co. Anima Biotech Inc....
Items per page:
1 - 6 of 6
BioCentury | Feb 26, 2021
Distillery Therapeutics

Blocking COL1 for multiple sclerosis

...fibrotic scar area in the spinal cord. Ongoing work includes identifying the molecular mechanisms that drive fibrosis.Anima Biotech Inc....
BioCentury | Jul 11, 2019
Emerging Company Profile

Twentyeight-Seven’s bet on RNA-binding proteins

...the anti-snRNP200 preclinical mAb AT1331 to treat subtypes of acute myelogenous leukemia (AML). Like Twentyeight-Seven, Anima Biotech Inc....
...Netherlands American Association for Cancer Research (AACR), Philadelphia, Pa. American Society of Hematology, Washington, D.C. Anima Biotech Inc....
BioCentury | Jun 21, 2019
Tools & Techniques

A human CRISPR-like system adds a new approach to regulating translation

...Inc. and Ribometrix Inc. -- have systematic techniques for identifying RNA-binding small molecules. Another company, Anima Biotech Inc....
...it and using the platform as a starting point for a company. Companies and institutions Anima Biotech Inc....
BioCentury | May 24, 2019
Emerging Company Profile

Anima opens new target space in translational control

...of target stability, tissue selectivity and the ability to tune protein expression up or down. Anima Biotech Inc....
...translation of a protein could dramatically increase production capability and efficiency,” he said. COMPANY PROFILE Anima Biotech Inc....
...Patents: 5 issued covering undisclosed IP Companies and Institutions Mentioned Accent Therapeutics Inc., Lexington, Mass. Anima Biotech Inc....
BioCentury | Jul 27, 2018
Company News

Lilly pairs up with protein translation company Anima

...Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors...
...Huntington disease. Anima Biotech Inc., Bernardsville, N.J. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Pharmaceuticals Elizabeth S. Eaton Anima Biotech Inc. Eli...
BioCentury | Jul 23, 2018
Company News

Lilly pairs up with protein translation company Anima

...Eli Lilly and Co. (NYSE:LLY) partnered with Anima Biotech Inc. (Bernardsville, N.J.) to discover and develop translation inhibitors...
...includes inhibitors to treat fibrosis, viral infections, cancer and Huntington disease. Elizabeth S. Eaton Eli Lilly and Co. Anima Biotech Inc....
Items per page:
1 - 6 of 6